Vero Biotech Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Vero Biotech's estimated revenue is currently $15.4M per year.
- Vero Biotech received $14.6M in venture funding in October 2013.
- Vero Biotech's estimated revenue per employee is $205333
- Vero Biotech has 75 Employees.
- Vero Biotech grew their employee count by 32% last year.
- Vero Biotech currently has 3 job openings.
|Leigh Davis||Director, Supply Chain|
|Katie Fisher||Senior Laboratory Director|
|Jennifer Mancuso||Vice President of Human Strategy|
|Michael Gentile||Vice President of Medical Affairs|
|Tod Shultz||Chief Strategy & Business Officer|
|Namita Khanna||Executive Director Strategic Development|
|Marcia Johnson||Vice President|
|Jason Molinari||Vice President Of New Product Development|
|Kim RenÃ© Jones||Director Quality Engineering|
|Christian Supina||Director of Quality Systems|
What Is Vero Biotech?
Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions. At Vero Biotech, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Premier Kids Ca...||$9.2M||48||4%|
Vero Biotech News
Lehigh alumni Rory Siegel, '18, and Liam Walsh, '17, are translating the skills gained as undergraduates to their work at Vero Biotech, where ...
ATLANTA, Oct. 5, 2018 /PRNewswire/ -- Vero Biotech LLC, a biopharmaceutical company focused on the design, development and ...
Vero Biotech, formerly GeNO LLC, designs, develops, and commercializes inhaled nitric oxide products for patients with cardiopulmonary ...
Vero Biotech Funding
Vero Biotech Executive Hires
|2013-08-28||Kurt A. Dasse||CEO||Article|
|2018-10-08||Michael Gentile||Vice President of Medical Affairs||Article|